An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Clinical trial NCT02497469 · COMPLETED
Trial details
- NCT number
- NCT02497469
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-29
- Primary completion
- 2018-09-26
- Enrollment
- 771
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.